References
- Laupacis A., Sackett D. L., Roberts R. S. An assessment of clinically useful measures of the consequences of treatment. N. Engl. J. Med. 1988; 318(26)1728–1733, [PUBMED], [INFOTRIEVE]
- Cook R. J., Sackett D. L. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310: 452–454, [PUBMED], [INFOTRIEVE]
- Cordell D. L. Number needed to treat (NNT). Ann. Emerg. Med. 1999; 33: 433–436, [PUBMED], [INFOTRIEVE], [CSA]
- Labbe K. A., Detsky A. S., O'Rourke K. Meta-analysis in clinical research. Ann. Intern. Med. 1987; 107: 224–233
- Richardson A. Screening and the number needed to treat. J. Med. Screen. 2001; 8(3)125–127, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Boomsma L. J., van Lidth de Jeude C. P. ‘Number needed to screen’: a tool for assessment of prevention programs. Ned. Tijdschr. Geneeskd. 2000; 144(49)2345–2348, [PUBMED], [INFOTRIEVE], [CSA]
- Cummings S. R., Black D. M., Thompson D. E., Applegate W. B., Barrett-Connor E., Musliner T. A., Palermo L., Prineas R., Rubin S. M., Scott J. C., Vogt T., Wallace R., Yates A. J., LaCroix A. Z. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 1998; 280(24)2077–2082, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Maceneaney P. M., Malone D. E. Applying ‘evidence-based medicine’ theory to interventional radiology. Part 2: a spreadsheet for swift assessment of procedural benefit and harm. Clin. Radiol. 2000; 55(12)938–945, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Oldridge N., Perkins A., Marchionni N., Fumagalli S., Fattirolli F., Guyatt G. Number needed to treat in cardiac rehabilitation. J. Cardiopulm. Rehabil. 2002; 22(1)22–30, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tramer M. R., Reynolds D. J., Stoner N. S., Moore R. A., McQuay H. J. Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review. Eur. J. Cancer 1998; 34(12)1836–1844, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lesaffre E., Boon P., Pledger G. W. The value of the number-needed-to-treat method in antiepileptic drug trials. Epilepsia 2000; 41(4)440–446, [PUBMED], [INFOTRIEVE], [CSA]
- Hwang P., Auclair B., Beechinor D., Diment M., Einarson T. R. Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis. Urology 1997; 50(1)39–43, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Riegelman R., Schroth W. S. Adjusting the number needed to treat: incorporating adjustments for the utility and timing of benefits and harms. Med. Decis. Mak. 1993; 13: 247–252, [CSA]
- Schultzer M., Mancini G. B.J. ‘Unqualified success’ and ‘unmitigated failure’: number needed-to-treat-related concepts for assessing treatment efficacy in the presence of treatment-induced adverse events. Int. J. Epidemiol. 1996; 25(4)704–712, [CSA]
- Sinclair J. C., Cook R. J., Guyatt G. H., Pauker S. G., Cook D. J. When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. J. Clin. Epidemiol. 2001; 54(3)253–262, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Walter S. D., Irwig L. Estimating the number needed to treat (NNT) index when the data are subject to error. Stat. Med. 2001; 20(6)893–906, [PUBMED], [INFOTRIEVE], [CROSSREF]
- McQuay H. J., Collins S. L., Carroll D., Moore R. A. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst. Rev. 2000, 2: CD001793, [CSA]
- Chatellier G., Zapletal E., Lemaitre D., Menard J., Degoulet P. The number needed to treat: a clinically useful nomogram in its proper context. BMJ 1996; 312(7028)426–429, [PUBMED], [INFOTRIEVE]
- Myrianthopoulos L., Vijayakumar S. The number needed to treat (NNT) and its applications in radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 2001; 51(3 Suppl. 1)370, [CROSSREF]
- Pignon J. P., Arriagada R., Ihde D. C., Johnson D. H., Perry M. C., Souhami R. L., Brodin O., Joss R. A., Kies M. S., Lebeau B., Onishi T., Osterlind K., Tattersall M. H.N., Wagner H. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N. Engl. J. Med. 1992; 327(23)1618–1624, [PUBMED], [INFOTRIEVE]
- Warde P., Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J. Clin. Oncol. 1992; 10(6)890–895, [PUBMED], [INFOTRIEVE]
- Fisher B., Dignam J., Wolmark N., Mamounas E., Costantino J., Poller W., Fisher E. R., Wickerham D. L., Deutsch M., Margolese R., Dimitrov N., Kavanah M. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J. Clin. Oncol. 1998; 16(2)441–452, [PUBMED], [INFOTRIEVE]
- Julien J. P., Bijker N., Fentiman I. S., Peterse J. L., Delledonne V., Rouanet P., Avril A., Sylvester R., Mignolet F., Bartelink H., Van Dongen J. A. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000; 355(9203)528–533, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Overgaard M., Hansen P. S., Overgaard J., Rose C., Andersson M., Bach F., Kjaer M., Gadeberg C. C., Mouridsen H. T., Jensen M. B., Zedeler K. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N. Engl. J. Med. 1997; 337(14)949–955, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ragaz J., Jackson S. M., Le N., Plenderleith I. H., Spinelli J. J., Basco V. E., Wilson K. S., Knowling M. A., Coppin C. M., Paradis M., Coldman A. J., Olivotto I. A. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N. Engl. J. Med. 1997; 337(14)956–962, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jani A. B., Basu A., Heimann R., Hellman S. Sentinel node versus axillary node dissection for early stage breast cancer: a comparison using a utility-adjusted NNT (number needed to treat) analysis. Cancer 2003; 97(2)359–366, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Smitt M. C., Buzydlowski J., Hoppe R. T. Over 20 years of progress in radiation oncology: Hodgkin's disease. Semin. Radiat. Oncol. 1997; 7(2)127–134, [PUBMED], [INFOTRIEVE]
- Hodgkin's Disease2nd ed., H. S. Kaplan. Harvard University Press, Cambridge, MA 1980
- Shah N. K., Freeman A. I., Friedman M., Stutzman L., Gaeta J., Rao A., Sinks L. F. Hodgkin's disease in children. Med. Pediatr. Oncol. 1976; 2(1)87–98, [PUBMED], [INFOTRIEVE]
- Hancock S. L., Hoppe R. T. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin. Radiat. Oncol. 1996; 6(3)225–242, [PUBMED], [INFOTRIEVE]
- Zelefsky M. J., Fuks Z., Happersett L., Lee H. J., Ling C. C., Burman C. M., Hunt M., Wolfe T., Venkatraman E. S., Jackson A., Skwarchuk M., Leibel S. A. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother. Oncol. 2000; 55(3)241–249, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Grimm P. D., Blasko J. C., Sylvester J. E., Meier R. M., Cavanagh W. 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 2001; 51(1)31–40, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Johansson J. E., Holmberg L., Johansson S., Bergstrom R., Adami H. O. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA 1997; 277(6)467–471, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Abdalla I., Basu A., Hellman S. An evidence-based analysis of the management of localized prostate cancer. J. Cancer 2002; 8(1)40–46
- Pilepich M. V., Winter K., John M. J., Mesic J. B., Sause W., Rubin P., Lawton C., Machtay M., Grignon D. Phase III radiation therapy oncology group (RTOG) trial 86–10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 2001; 50(5)1243–1252, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rebecca W., Richard M. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst. Rev. 2001, 2: CD002092, [CSA]
- Murakami M., Kuroda Y., Nakajima T., Okamoto Y., Mizowaki T., Kusumi F., Hajiro K., Nishimura S., Matsusue S., Takeda H. Intraoperative radiotherapy for the abdominal lymphatic system in patients with esophageal carcinoma. Dis. Esophagus 1999; 12(4)270–275, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vijayakumar S., Hellman S. Advances in radiation oncology. Lancet 1997; 349(Suppl. 2)SII1–SII3, [PUBMED], [INFOTRIEVE]
- PORT Meta-Analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998; 352(9124)257–263, [CROSSREF]
- Black H. R., Crocitto M. T. Number needed to treat: solid science or a path to pernicious rationing?. Am. J. Hypertens. 1998; 11(8 Pt. 2)128S–134S, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wu L. A., Kottke T. E. Number needed to treat: caveat emptor. J. Clin. Epidemiol. 2001; 54(2)111–116, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jani A. B., Vaida F., Hanks G., Asbell S., Sartor O., Moul J. W., Roach M., III, Brachman D., Kalokhe U., Muller-Runkel R., Ray P., Ignacio L., Awan A., Weichselbaum R. R., Vijayakumar S. Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era. Int. J. Cancer 2001; 96(6)363–371, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 1992; 268(17)2420–2425, [CROSSREF]
- Edwards A., Elwyn G., Hood K., Rollnick S. Judging the ‘weight of evidence’ in systematic reviews: including rigour into the qualitative overview stage by assessing signal and noise. J. Eval. Clin. Pract. 2000; 6(2)177–184, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McGettigan P., Sly K., O'Connell D., Hill S., Henry D. The effects of information framing on the practices of physicians. J. Gen. Intern. Med. 1999; 14(10)633–643, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]